Finally, although hypoalbuminemia has been demonstrated to be a risk factor of polymyxin AKI, hypoalbuminemia correction by administering exogenous albumin with the hope of preventing or mitigating nephrotoxicity has no clinical data so far and it is not advisable. Here, ALB is linked to acute kidney injury.